EUVIMEDEUVIMED entdecken
KommentarOpen Access

Prognostic Impact of Fluorescent Lymphography on Gastric Cancer After Neoadjuvant Chemotherapy

Yi-Hui Tang, Ze-Ning Huang, Yu-Qin Sun, Ya-Qi Zhao, Wen-Wu Qiu, Ji-Xun He, Ping Li, Jian-Wei Xie, Jia-Bin Wang, Qi-Yue Chen, Long-Long Cao, Chao-Hui Zheng und 3 weitere

JAMA Surgery · 01.05.2025 · 160 (5) · 554

DOI: 10.1001/jamasurg.2025.0108 ↗

Kurz gefasst

Kommentar in der Zeitschrift JAMA Surgery, erschienen am 01.05.2025. Verfasst von Yi-Hui Tang und 14 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou, China. Hauptthemen laut MEDLINE: Stomach Neoplasms, Indocyanine Green, Lymph Node Excision, Adenocarcinoma. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Importance Indocyanine green (ICG)–guided lymphadenectomy has been increasingly used to treat gastric cancer. However, its oncologic impact remains unclear.

Objective

To investigate the effect of ICG tracing on long-term outcomes in patients diagnosed with locally advanced gastric cancer undergoing neoadjuvant chemotherapy (NAC) followed by laparoscopic radical gastrectomy. Design, Settings, and Participants This retrospective cohort study included patients diagnosed with cT2-4N0/+M0 gastric adenocarcinoma who underwent NAC and laparoscopic radical gastrectomy at 3 teaching hospitals in China between January 2015 and June 2021, with follow-up data examined until June 2024. Overlap weighting (OW) was used to compare outcomes between the ICG and non–ICG groups. Results were tested for robustness using propensity score matching (PSM) and instrumental variable analysis. Exposure ICG–guided lymphadenectomy during laparoscopic gastrectomy. Main Outcomes and Measures The primary end points were 3-year survival outcomes, including overall survival (OS) and recurrence-free survival (RFS).

Results

Data from 459 patients (338 men [73.6%] and 121 women [26.4%]; mean [SD] age, 60.8 [9.9] years), of whom 119 underwent ICG–guided lymphadenectomy, were included. After OW adjustment, the ICG group exhibited a higher number of lymph nodes harvested (47.4 vs 38.3; P < .001) and better 3-year OS (78.6% vs 66.6%; P = .04) and RFS (74.0% vs 57.0%; P = .03) compared with the non–ICG group. Multivariable Cox regression analysis revealed that ICG tracing was an independent prognostic factor for both OS (hazard ratio, 0.59; 95% CI, 0.39-0.90; P = .02) and RFS (hazard ratio, 0.59; 95% CI, 0.40-0.87; P = .01), with the results remaining significant in both doubly robust and instrumental variable-adjusted models. Furthermore, in the OW–adjusted population, the OS benefit of ICG tracing was more pronounced in subgroups with ypN2/3 gastric adenocarcinoma (70.3% vs 36.2%; P = .01) and those achieving major pathological response (97.7% vs 77.6%; P = .04) (both P for interaction = .04). Similar results were obtained after adjusting for PSM. Conclusion and Relevance In this study, ICG tracing was associated with enhanced lymphadenectomy and improved survival outcomes in patients with locally advanced gastric cancer after NAC. A prospective randomized clinical trial is needed to verify these findings.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Stomach NeoplasmsIndocyanine GreenLymph Node ExcisionAdenocarcinomaLymphographyHumansMaleFemaleMiddle AgedRetrospective StudiesNeoadjuvant TherapyGastrectomyPrognosisLaparoscopyAgedChemotherapy, Adjuvant

Substanzen

Indocyanine Green

Autor:innen und Institutionen

  • Department of Gastric Surgery, Fujian Medical University Union Hospital, Fuzhou, China.
  • Department of General Surgery, Fujian Medical University Union Hospital, Fuzhou, China.
  • Fujian Province Minimally Invasive Medical Center, Fuzhou, China.
  • Laboratory of Gastrointestinal Cancer, Fujian Medical University, Ministry of Education, Fuzhou, China.
  • Department of Gastrointestinal Surgery, Zhangzhou Affiliated Hospital of Fujian Medical University, Zhangzhou, China.
  • Department of Gastrointestinal Surgery, Qinghai University Affiliated Hospital, Xining, China.

Zitieren

APA

Tang, Y. H., Huang, Z. N., Sun, Y. Q., Zhao, Y. Q., Qiu, W. W., He, J. X., Li, P., Xie, J. W., Wang, J. B., Chen, Q. Y., Cao, L. L., Zheng, C. H., Lin, J. X., Yan, S., & Huang, C. M. (2025). Prognostic Impact of Fluorescent Lymphography on Gastric Cancer After Neoadjuvant Chemotherapy. JAMA Surgery, 160(5), 554. https://doi.org/10.1001/jamasurg.2025.0108

Vancouver

Tang YH, Huang ZN, Sun YQ, Zhao YQ, Qiu WW, He JX, et al. Prognostic Impact of Fluorescent Lymphography on Gastric Cancer After Neoadjuvant Chemotherapy. JAMA Surgery. 2025;160(5):554. doi:10.1001/jamasurg.2025.0108

BibTeX
@article{Tang2025,
  author = {Tang, Yi-Hui and Huang, Ze-Ning and Sun, Yu-Qin and Zhao, Ya-Qi and Qiu, Wen-Wu and He, Ji-Xun and Li, Ping and Xie, Jian-Wei and Wang, Jia-Bin and Chen, Qi-Yue and Cao, Long-Long and Zheng, Chao-Hui and Lin, Jian-Xian and Yan, Su and Huang, Chang-Ming},
  title = {Prognostic Impact of Fluorescent Lymphography on Gastric Cancer After Neoadjuvant Chemotherapy},
  journal = {JAMA Surgery},
  year = {2025},
  volume = {160},
  number = {5},
  pages = {554},
  doi = {10.1001/jamasurg.2025.0108}
}
Kostenlos starten →